GGrantIndex
← Search

RAPID PRECLINICAL DEVELOPMENT OF A NOVEL ORAL MEDICINE FOR PREVENTION AND TREATMENT OF ENTEROTOXIGENIC ESCHERICHIA COLI DIARRHEAL DISEASE.

$1,539,634FY2021Defense Health AgencyDOD

University Of Massachusetts Medical School, Worcester MA

Investigators

View source on USAspending →